Other markers are under study, and supporting the fact that some CD133 negative cells are able to form tumors in immunocompromised mice [11], suggesting that additional markers are necessary for the identification of glioma CSCs due to their heterogeneous nature. Here, PROM1 is linked to central nervous system cancer.